Johnson & Johnson (JNJ)
199.96
-1.66
(-0.82%)
USD |
NYSE |
Dec 09, 16:00
200.33
+0.37
(+0.19%)
After-Hours: 20:00
Johnson & Johnson EPS Diluted (Quarterly): 2.121 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Eli Lilly & Co. | 6.211 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Protagonist Therapeutics, Inc. | -0.6169 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.152B |
| Revenue (Quarterly) | 23.99B |
| Total Expenses (Quarterly) | 18.84B |
| Enterprise Value | 509.00B |
| Gross Profit Margin (Quarterly) | 69.72% |
| Profit Margin (Quarterly) | 21.47% |
| Earnings Yield | 5.18% |
| Operating Earnings Yield | 4.90% |
| Normalized Earnings Yield | 4.263 |